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Background: Validity of current International Classification 
of Disease/Diagnostic and Statistical Manual of Mental 
Disorders (ICD/DSM) first episode psychosis diagnoses is 
essential in clinical practice, research, training and public 
health. Method: We provide a meta-analytical estimate of 
prospective diagnostic stability and instability in ICD-10 
or DSM-IV first episode diagnoses of functional psycho-
ses. Independent extraction by multiple observers. Random 
effect meta-analysis conducted with the “metaprop,” 
“metaninf,” “metafunnel,” “metabias,” and “metareg” 
packages of STATA13.1. Moderators were tested with 
meta-regression analyses. Heterogeneity was assessed 
with the I2 index. Sensitivity analyses tested robustness of 
results. Publication biases were assessed with funnel plots 
and Egger’s test. Findings: 42 studies and 45 samples were 
included, for a total of 14 484 first episode patients and 
an average follow-up of 4.5 years. Prospective diagnostic 
stability ranked: schizophrenia 0.90 (95% CI 0.85–0.95), 
affective spectrum psychoses 0.84 (95% CI 0.79–0.89), 
schizoaffective disorder 0.72 (95% CI 0.61–0.73), sub-
stance-induced psychotic disorder 0.66 (95% CI 0.51–
0.81), delusional disorder 0.59 (95% CI 0.47–0.71), acute 
and transient psychotic disorder/brief psychotic disorder 
0.56 (95% CI 0.62–0.60), psychosis not otherwise specified 
0.36 (95% CI 0.27–0.45, schizophreniform disorder 0.29 
(95% CI 0.22–0.38). Diagnostic stability within schizo-
phrenia spectrum psychoses was 0.93 (95% CI 0.89–0.97); 
changes to affective spectrum psychoses were 0.05 (95% 
CI 0.01–0.08). About 0.10 (95% CI 0.05–0.15) of affec-
tive spectrum psychoses changed to schizophrenia spec-
trum psychosis. Across the other psychotic diagnoses there 
was high diagnostic instability, mostly to schizophrenia. 
Interpretation: There is meta-analytical evidence for high 
prospective diagnostic stability in schizophrenia spectrum 
and affective spectrum psychoses, with no significant ICD/
DSM differences. These results may inform the develop-
ment of new treatment guidelines for early psychosis and 
impact drug licensing from regulatory agencies.
Key words:  schizophrenia/diagnostic stability/ 
psychosis/ICD/DSM
Introduction
Unlike most of other areas of medicine, psychiatric 
diagnoses, as operationalized in the International tax-
onomies represented by the World Health Organization’s 
(International Classification of Diseases [ICD of WHO]) 
and American Psychiatric Association’s (Diagnostic and 
Statistical Manual of Mental Disorders [DSM of APA]), 
are derived from expert opinion,1 with the specific aim 
of improving reliability across clinicians. The National 
Institute of Mental Health commented: “unlike our defi-
nitions of ischemic heart disease, lymphoma or AIDS, 
the DSM diagnoses are based on a consensus about clus-
ters of clinical symptoms, not any objective laboratory 
measure.”2 Since no objective tests or markers are on the 
horizon,3 clinical psychiatry is anchored to “the patient’s 
altered experience, expression and existence, associated 
with suffering in self  and/or others.”4 Therefore, assess-
ing validity of current diagnostic classification based on 
psychopathology4 is essential, in particular for patients at 
their first contact with mental health services.
The quantification of diagnostic stability and instabil-
ity of first episode psychosis diagnoses is of paramount 
practical import,5 to ensure diagnostic validity6 and opti-
mize early interventions,7 in light of the limited treat-
ment achievements in the late stages of the disorder.8,9 
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For example, evidence of diagnostic stability within the 
schizophrenia spectrum psychoses and affective spec-
trum psychoses is fundamental to guide accurate early 
interventions. The National Institute of Health and Care 
Excellence (NICE) recommends the clinical guideline 
178 (CG178) for schizophrenia spectrum psychoses, but 
CG38/90 in case of affective spectrum psychoses (rec-
ommendation 1.3.4.310). These guidelines make substan-
tive differential clinical recommendations such as use of 
pharmacological and psychological interventions, infor-
mation and support for carers and patients, management 
of crisis and risk, long term care and strategies to pro-
mote recovery.10 Several studies addressing diagnostic 
stability of first episode psychosis diagnoses have been 
published, but the results are highly heterogeneous. For 
example, some studies suggested that the first episode 
schizoaffective disorder has the highest 2 years prospec-
tive diagnostic stability, followed by affective spectrum 
psychoses and only in third ranking by schizophrenia.11 
Contrasting findings suggested that first episode schizo-
phrenia exhibited the highest 2 years prospective diagnos-
tic stability, and the schizoaffective disorder the lowest 
stability.12 Similarly, some studies found a greater stabil-
ity for some first episode psychosis diagnoses as assigned 
using ICD-10 rather than DSM-IV criteria in the same 
patients,11 while others found the 2 systems to have simi-
lar prospective consistency.13
We present here the first meta-analysis of the diagnos-
tic stability and instability of ICD-10/DSM-IV functional 
first episode psychosis diagnoses. Our first aim was to test 
the magnitude and consistency of prospective diagnos-
tic stability of first episode psychosis diagnoses, while at 
the same time addressing diagnostic changes over time. 
Our analysis was complemented by investigation of some 
potential moderators (eg, ICD-10 vs DSM-IV). Our sec-
ondary aim was to meta-analytically address the magni-
tude of retrospective diagnostic stability of first episode 
psychosis diagnoses.
Methods
Search Strategy
Two independent investigators (M.C., Z.B.) conducted 
2-step literature searches according to a specific proto-
col. First, the Web of Knowledge database was searched, 
incorporating both the Web of Science and MEDLINE. 
The search was extended until June 30, 2015, includ-
ing abstracts in English language only. The electronic 
research adopted several combinations of the following 
keywords: “First episode psychosis,” “Diagnostic accu-
racy,” “Sensitivity,” “Specificity,” “Psychosis prediction,” 
“Psychosis onset,” “Diagnostic stability,” “Prediction,” 
“DSM-IV,” “ICD-10,” and “Follow-up”. Second, we used 
Scopus to investigate citations of possible previous reviews/
meta-analyses on diagnostic stability of first episode psy-
chosis diagnoses, and a manual search of the reference 
lists of retrieved articles. Articles identified through these 2 
steps were then screened for the selection criteria on basis 
of abstract reading. The articles surviving this selection 
were assessed for eligibility on basis of full-text reading, 
following the MOOSE checklist (supplementary table 1).14
Selection Criteria
Studies were eligible for inclusion if  the following cri-
teria were fulfilled: (a) were original articles, written in 
English; (b) included a group of ICD-10 or DSM-IV/
DSM-IV-TR first episode psychosis patients (defined as 
first-ever admission to mental health services), diagnosti-
cally assessed at baseline and follow-up; and (c) reported 
the baseline and follow-up number of specific psychotic 
diagnoses: schizophrenia, schizoaffective disorders, 
schizophreniform disorder, affective spectrum psychoses, 
delusional disorder, substance-induced psychotic disor-
der, psychosis not otherwise specified, acute and tran-
sient psychotic disorder/brief  psychotic disorder. Further 
details on the specific ICD-10/DSM-IV diagnostic codes 
are appended in supplementary methods. When data were 
not directly presented they were indirectly extracted from 
associated data. Corresponding authors were contacted 
to retrieve additional data when possible. Exclusion cri-
teria were: (a) abstracts, pilot datasets, and papers in lan-
guages other than English; (b) articles not employing the 
internationally ICD/DSM validated diagnoses for psy-
chosis; (c) articles not providing enough meta-analytical 
data; (d) articles reporting on organic psychoses, and (e) 
articles with overlapping datasets. Specifically, in case of 
multiple publications deriving from the same study popu-
lation, we selected the articles reporting the largest and 
most recent data set. Literature search was summarized 
according to the PRISMA guidelines.15
Recorded Variables
Data extraction was independently performed by 2 inves-
tigators (M.C., Z.B.). To estimate the primary outcome 
variable we extracted the baseline sample size and the 
number of patients with specific psychotic diagnoses 
at follow-up time. Moderators tested in meta-regres-
sion analyses are detailed below. Quality assessment is 
described below here.
Quality Assessment
Quality assessment in observational research is contro-
versial, with no clear consensus on rating methods or 
their appropriate use in the analysis. We adapted the 
Newcastle Ottawa Scale (NOS) for the evaluation of 
nonrandomized studies (http://www.ohri.ca/programs/
clinical_epidemiology/oxford.asp). The scale evaluates 
the quality of  observational studies allocating a maxi-
mum of  9 stars for higher quality. This tool has been 
adopted in recent meta-analyses.16
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Statistical Analysis
The primary outcome is the prospective diagnostic sta-
bility/instability of ICD/DSM first episode psychosis 
diagnoses over time. The prospective diagnostic stability 
is defined as the proportion of baseline patients retain-
ing the same psychotic diagnosis over time.12 In case of 
remission or full recovery at follow-up, the initial diag-
nosis is unchanged. The prospective diagnostic instability 
of first episode psychosis diagnoses over time is defined 
as the complementary proportion of baseline patients 
shifting to other diagnoses at follow-up. The prospec-
tive diagnostic stability/instability was computed across 
each initial diagnostic category. We performed addi-
tional analyses clustering the individual diagnoses across 
diagnostic spectra relevant for the NICE clinical guide-
lines10: schizophrenia spectrum psychoses (schizophre-
nia, schizophreniform disorder, schizoaffective disorder) 
and affective spectrum psychoses (mania with psychosis 
and/or bipolar disorder with psychosis and/or depression 
with psychosis). The secondary outcome is the retrospec-
tive diagnostic stability/instability across each diagno-
sis, defined as the proportion of follow-up patients that 
receives the same diagnosis that they had at baseline, or 
another diagnosis as compared to that received at base-
line respectively.12 Meta-analysis was conducted with 
the “metaprop” package17 of Stata 13.1. This package is 
specifically developed for pooling proportions in a meta-
analysis of multiple studies. The CIs are based on score 
(Wilson) procedures.18 As proportions were expected to 
be often small we used Freeman-Tukey Double Arcsine 
transformation19 to stabilize the variances and then we 
performed a random effect meta-analysis implement-
ing the Der Simonian-Laird method.20 The influence of 
moderators (age, gender, time to follow-up, comorbid 
substance abuse, ICD-10 vs DSM-IV diagnostic crite-
ria, publication year, quality assessment, clinical setting 
of initial diagnosis, baseline functional level measured 
with the Global Assessment of Functioning [GAF] 
scale, duration of untreated psychosis) on the diagnostic 
instability of each diagnostic category was tested using 
meta-regression analyses with the “metareg” function.21 
The slope of meta-regression line (β-coefficient: direct 
[+] or inverse [−]) indicates the strength of a relationship 
between moderator and outcome. The meta-regressions 
were conducted when at least 10 studies were available for 
each moderator.22 Because of the large number of regres-
sions the alpha level was reduced to .0123 as a compromise 
between a strict control of the familywise error and not 
having any power to detect any relationships. Tests with 
a P value between .01 and .05 were discussed as trends. 
Subgroup analyses were additionally used to further 
investigate the impact of ICD-10 vs DSM-IV criteria on 
diagnostic stability and instability of each specific psy-
chotic diagnosis. Heterogeneity among study point esti-
mates was assessed using Q statistics with the proportion 
of the total variability in the effect size estimates being 
evaluated with the I2 index,24 which does not depend 
upon the number of studies included. As meta-analysis 
of observational studies is supposed to be characterized 
by significant heterogeneity, random effect models were 
used. Sensitivity analyses were also conducted to inves-
tigate the influence of each single study on the overall 
prospective diagnostic instability by omitting 1 study at a 
time, using Stata’s user-written function, “metaninf.”25,26 
A  study was considered to be influential if  the pooled 
mean estimate without it was not within the 95% con-
fidence bounds of the overall mean. Publication biases 
were assessed with the “metafunnel” function of Stata 
which produced funnel plots for assessing small-study 
reporting bias in meta-analysis27 and with the “metat-
rim”28 function of Stata.
Results
Database
Literature search (PRISMA flow-chart figure 1) uncov-
ered 42 independent articles. The list of excluded studies 
is detailed in the supplementary table 2. There were 23 
studies employing ICD-10 and 22 employing DSM-IV, 
with 3 studies contributing 2 samples (ICD-10 and 
DSM-IV) each,13,29,30 for an overall of 45 independent 
samples. The final database comprised 14 484 first epi-
sode patients, 10 510 diagnosed with ICD-10 and 3974 
diagnosed with DSM-IV. The mean age of the patients 
was 29  years (median 27  years, age range 16–75) and 
the mean proportion of females was 0.49. Age, gender, 
diagnostic instrument employed to assign the psychotic 
diagnosis, quality assessment, baseline sample size are 
detailed in table 1, while duration of untreated psychosis 
and operationalization of first episode of psychosis are 
detailed in supplementary table  3. The mean follow-up 
time was 4.5 years (n = 45, 53.86 months, SD = 51.51, 
IQR 23–77). All studies but one31 employed the same 
diagnostic instrument at baseline and follow up.
Meta-analytical Prospective Diagnostic Stability of 
ICD/DSM First Episode Psychosis Diagnoses
Meta-analytical diagnostic stability of first episode 
psychosis diagnoses across each diagnostic category is 
detailed in the boldfaced diagonal of table 2, while diag-
nostic instability is detailed in the other cells. Between 
group analyses found no ICD-10 vs DSM-IV significant 
differences.
Point estimate diagnostic stability of first episode 
psychosis diagnoses was highest for schizophrenia 
(0.90), and high for affective spectrum psychoses (0.84). 
Diagnostic stability was moderate for schizoaffective dis-
order (0.72) and moderate to low for substance-induced 
psychotic disorder (0.66), delusional disorder (0.59) and 
acute psychotic disorder/ brief  psychotic disorder (0.56). 
Diagnostic stability was very low for psychosis not oth-
erwise specified (0.36) and schizophreniform disorder 
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(0.29). In a subset of studies we further addressed the 
diagnostic stability of mania/bipolar disorder with psy-
chosis (0.90) and depression with psychosis (0.73) sepa-
rately (supplementary table 4).
When the analyses were repeated across the schizo-
phrenia vs affective psychosis spectra (table 3), diagnos-
tic stability of schizophrenia spectrum psychoses was 
0.93, while for affective spectrum psychoses it was 0.84. 
Changes from a schizophrenia spectrum to an affective 
spectrum were infrequent, accounting for only 0.05 of 
initial cases. On the other hand, about 0.1 of initial affec-
tive spectrum psychoses shifted towards schizophrenia 
spectrum psychoses.
About one-third of the initial cases of delusional dis-
orders shifted towards schizophrenia spectrum disor-
ders (0.29 schizophrenia, 0.04 schizoaffective disorder). 
Diagnostic changes were also frequent from an initial 
acute and transient psychotic disorder/brief psychotic 
disorder: one-fourth of them towards schizophrenia spec-
trum disorders (0.21 schizophrenia, 0.02 schizophreniform 
disorder, 0.02 schizoaffective disorder) and 0.12 of them 
towards affective spectrum psychoses. Substance-induced 
psychotic disorder shifted most frequently towards schizo-
phrenia spectrum psychoses (0.17 schizophrenia, 0.04 
schizoaffective disorder, 0.02 schizophreniform disorder). 
Among the initial cases of  psychosis not otherwise speci-
fied, about one-third (0.36) retained the initial diagnosis 
and one-third (0.31) shifted towards schizophrenia.
Meta-regressions, Publication Biases, and Sensitivity 
Analyses
Meta-regressions analyses across each psychotic category 
clarified that the publication year impacted diagnostic 
instability of schizophrenia, schizophreniform disorder, 
delusional disorder (at trend level uncorrected for multiple 
comparisons) and acute and transient psychotic disor-
der/brief psychotic disorder (corrected for multiple com-
parisons, supplementary table  5), with higher instability 
over the most recent years. Similarly, the inpatient setting 
Fig. 1. PRISMA Flow Chart.
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during formulation of an initial diagnosis was associated 
with reduced diagnostic instability as compared to a mixed 
setting for schizophrenia, affective spectrum psychoses, 
delusional disorder (at trend level uncorrected for multiple 
comparisons), acute and transient psychotic disorder/brief  
psychotic disorder (corrected for multiple comparisons, 
supplementary table 5). A better quality of studies was asso-
ciated with increased diagnostic instability for acute and 
transient psychotic disorder/brief psychotic disorder (cor-
rected for multiple comparisons, supplementary table 5). 
There was no effect for age, gender, comorbid substance 
abuse, baseline ICD-10 or DSM-IV diagnostic criteria, 
Table 1. List of Studies Included in the Meta-analysis
Study Name and Year of Publication
NOS Score (9 = Max.); 
Comorbid Substance 
Misuse (%)
Diagnostic 
Manual
FEP Whole 
Sample
Age  
(Mean ± SD)
Gender 
(% Females)
Follow-up 
(Months ± SD)
1. Okasha, et al 199332 5; NA ICD-10 50 27 ± 9.8 50 12 ± NA
2. Jørgensen, et al 199533 5; NA ICD-10 75 43 ± 14 60 96 ± NA
3. Jørgensen, et al 199734 6; NA ICD-10 46 NA NA 12 ± NA
4. Das, et al 199935 4; No ICD-10 40 25.7 ± 9 70 1 ± NA
5. Schwartz, et ala 200012 8; Yes (30.2) DSM-IV 514b 28 ± NA NA 24 ± NA
6. Sajith, et al 200236 6; NA ICD-10 45 26.9 ± 10.9 71.1 36.5 ± NA
7. Jäger, et al 200331 5; NA ICD-10 73 31.8 ± 14.6 50.7 60 ± NA
8. Jarbin, et al 200337 6; Yes (NA) DSM-IV 67b 16 ± NA 51.5 122.4 ± NA
9. Amini, et al 200529 6; Yes (NA) DSM-IV; 
ICD-10
48 23.5 ± 7.7 45.8 12 ± NA
10. Correll, et al 200538 5; Yes (NA) DSM-IV 26 16.2 ± 2.7 34.5 22.8 ± 19.8
11. Rufino, et al 200539 4; No DSM-IV 59 NA 27.1 19.4 ± 6.1
12. Schimmelmann, et al 200540 6; Yes (59.1) DSM-IV 492 22 ± 3.6 36.8 18 ± NA
13. Suda, et al 200541 6; NA ICD-10 25 37.8 ± 9.5 76 116.4 ± 45.6
14. Whitty, et al 200542 6; Yes (NA) DSM-IV 147 NA NA 48 ± NA
15. Abe, et al 200643 5; NA ICD-10 16 34.8 ± 9.9 50 144 ± NA
16. Addington, et al 200644 7; Yes (43) DSM-IV 228 24.5 ± 8.2 32.9 12 ± NA
17. Thangadurai, et al 200645 4; NA ICD-10 87 29.8 ± 11 48 13.2 ± 11.7
18. Boks, et al 200646 5; NA DSM-IV 29 26.9 ± 6.3 37.9 24 ± NA
19. Rahm, et al 200747 6; Yes (NA) DSM-IV 146 NA NA 36 ± NA
20. Subramaniam, et al 200748 6; No DSM-IV 154 28.4 ± 6.6 49 24 ± NA
21. Fraguas, et al 200849 4; No DSM-IV 24 15.7 ± 1.6 25 24
22. Haahr, et al 200850 6; Yes (38) DSM-IV 279b NA NA 24 ± NA
23. Chang, et al 200951 6; Yes (11.7) ICD-10 166 19.8 ± 3.1 46.4 53.4 ± 13.3
24. Crebbin, et al 200952 6; Yes (100) ICD-10 35 25.6 ± 8.4 17.1 24 ± NA
25. Pedrós, et al 200953 7; Yes (NA) DSM-IV 48 28.1 ± 8.7 NA 24 ± NA
26. Salem, et al 200954 5; NA ICD-10 69 27.5 ± 6.6 32.4 72 ± NA
27. Salvatore, et al 200955 7; Yes (51.2) DSM-IV-TR 500 31.7 ± 13.7 45 24 ± NA
28. Aadamsoo, et al 201156 6; NA ICD-10 107 NA 60 24 ± NA
29. Barak, et al 201157 5; Yes (NA) ICD-10 83 75.4 ± 9.3 56.6 27.7 ± NA
30. Castro-Fornieles, et al 201158 7; Yes (NA) DSM-IV 83 15.5 ± 1.7 32.5 24 ± NA
31. Kim, et al 201159 6; No DSM-IV 150 27.7 ± 9.5 NA 27.1 ± 25.3
32. Möller, et al 201130 8; NA DSM-IV; 
ICD-10
136; 123 NA NA 180 ± NA
33. Salvatore, et al 201111 8; Yes (51.2) ICD-10 500 31.7 ± 13.7 45 24 ± NA
34. Narayanaswamy, et al 201260 5; Yes (8.8) ICD-10 57 30.7 ± 11.8 65 24 ± NA
35. Pillmann, et al 201261 7; NA ICD-10 71 NA NA 148.8 ± 87.6
36. Kingston, et ala 201362 8; No DSM-IV 187b 42.7 ± 18.6 41.3 76.8 ± 27.6
37. Pope, et al 201363 6; Yes (31.3) DSM-IV-TR 214 22.6 ± 4 30.4 12 ± NA
38. Castagnini & Foldager 201464 8; Yes (NA) ICD-10 5426 28 ± 11.7 47.4 111.6
39. Kapfhammer, et al 201465 6; No DSM-IV-TR 55b NA NA 144 ± NA
40. Queirazza, et al 201466 7; Yes (NA) ICD-10 2923 37.4 ± 17.7 45.5 48 ± 47.6
41. Heslin, et al 201513 8; Yes (NA) DSM-IV-TR; 
ICD-10
402b; 401b 30.8 ± 10.7 42.9 128.9 ± 14
42. Ranjan, et al 201567 5; NA ICD-10 30 NA NA 3 ± NA
Note: DSM-IV/IV-TR, Diagnostic and Statistical Manual of Mental Disorders, 4th Edition/Text Revision; ICD-10; International 
Statistical Classification of Diseases and Related Health Problems, 10th Edition; FEP, First Episode Psychosis; NA, data not available; 
NOS, Newcastle Ottawa Scale.
aExtended baseline assessment.
bAfter excluding patients not meeting inclusion criteria (ie, with organic psychoses or with non-psychotic diagnoses).
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baseline GAF level and duration of follow-up while there 
were not enough studies to investigate the effect of dura-
tion of untreated psychosis (supplementary table 5).
Visual inspection of funnel plots revealed no asym-
metry, and metatrim analyses identified no studies to cut 
and fill (supplementary figure 1). Sensitivity analyses of 
overall diagnostic instability of ICD-10 (supplementary 
figure 2a) and DSM-IV (supplementary figure 2b) studies 
uncovered no outliers and confirmed robustness of results.
Meta-analytical Retrospective Diagnostic Stability of 
ICD/DSM First Episode Psychosis Diagnoses
Meta-analytical retrospective diagnostic stability was 
high for acute and transient psychotic disorder/brief  psy-
chotic disorder and schizophreniform disorder, modest 
for affective spectrum psychoses and delusional disor-
der, low for schizophrenia and schizoaffective disorder, 
psychosis not otherwise specified and substance-induced 
psychotic disorder (supplementary table 6), averaging 0.6 
for schizophrenia spectrum psychoses and 0.64 for affec-
tive spectrum psychoses (supplementary table 7).
Discussion
We present here the first meta-analytical estimate of diag-
nostic stability of first episode psychosis diagnoses. Our 
database was large, including 42 studies and 45 samples for 
a total of 14 484 subjects, followed up for a mean period 
of 4.5 years. There was significant construct variability68 
across prospective diagnostic stability of different first-
episode psychotic diagnoses: schizophrenia 0.90, affective 
spectrum psychoses 0.84, schizoaffective disorder 0.72, 
substance-induced psychotic disorder 0.66, delusional 
disorder 0.59, acute and transient psychotic disorder/brief  
psychotic disorder 0.56, psychosis not otherwise specified 
0.36, and schizophreniform disorder 0.29.
This is the first robust meta-analytical evidence docu-
menting a very high diagnostic stability of schizophre-
nia, which is comparable to other clinical diagnoses in 
medicine. For example, a study in 4141 patients affected 
with dementia or mild cognitive impairment reported 
a similar (2 y) prospective diagnostic stability of 0.91.69 
Another study in 783 patients affected with migraine or 
tension type headache reported a (7 mo) diagnostic sta-
bility of 0.66 and 0.63, respectively.70 Prospective stability 
of specific first-episode diagnoses may be of relevance for 
agencies licensing the use of drugs and medical devices 
such as the Food and Drug Administration (FDA) in the 
United States or the Medicines & Healthcare Products 
Regulatory Agency (MHRA) in United Kingdom and 
the European Medicine Agency (EMA) in the European 
Union. For example, the FDA has approved the use of 
paliperidone for the treatment of schizophrenia and 
schizoaffective disorder only, risperidone for schizophre-
nia and bipolar disorder (and irritability associated with 
autism), fluphenazine for psychotic disorders in general.71 
Clozapine is licensed only for treatment resistant or sui-
cidal risk schizophrenia.71 The off-license use of these 
medications for psychotic diagnoses is common72 and 
may have legal or health economic implications.
On a clinical level, not all aspects of diagnostic insta-
bility are negative. Although evidence of diagnostic stabil-
ity is one of the key criteria for establishing the validity 
of most first episode psychosis diagnoses,6 some nosologic 
categories (eg, schizophreniform disorder or psychosis not 
otherwise specified) are formulated a priori on expected 
diagnostic uncertainty at the onset of psychosis or inad-
equate information available for specific diagnosis. Such 
diagnostic categories are intended as “place-holders.” 
Frequent diagnostic shifts in these disorders are to be 
expected. Interestingly, we found that about one-third of 
initial cases of schizophreniform disorder or psychosis not 
otherwise specified retained their initial diagnosis, suggest-
ing some ongoing clinical uncertainty or clinician reluc-
tance to specify a category. To overcome these issues and 
better understand the clinical relevance of our findings, 
we reported a high diagnostic stability across schizophre-
nia spectrum psychoses (0.93), as well as across affective 
spectrum psychoses (0.84). Changes from schizophrenia 
spectrum to affective spectrum were infrequent (0.05), and 
about 0.1 of the initial affective spectrum psychoses shifted 
towards schizophrenia spectrum psychoses. These findings 
may be of direct clinical relevance to clinicians who are 
required to follow the differential NICE guidelines for 
early schizophrenia spectrum vs affective spectrum psy-
choses. The concern that initial first-episode diagnosis, if  
incorrect, may impede clinical care is particularly relevant 
for changes between schizophrenic and affective spectra 
and less so within the same spectrum. Differences between 
an initial diagnosis of major depressive disorder with psy-
chotic features and that of schizophrenia are profound, not 
only in the pharmacotherapies and specific forms of psy-
chological therapy typically used “but also in the descrip-
tions provided to newly diagnosed individuals and their 
families as to what lies ahead.”5 Indeed, recent epidemio-
logical studies in first episode samples have confirmed that 
schizophrenia spectrum diagnoses have a worse clinical, 
social and service use course and outcome as compared to 
affective spectrum diagnoses.73
The additional clinically relevant finding of our meta-
analysis is of no significant differences across ICD-10 vs 
DSM-IV definitions of each first episode diagnosis, as 
revealed by meta-regression analyses. Such a result may 
well reflect the increasing effort of international diagnos-
tic manuals to improve reliability of psychiatric diagno-
ses and to harmonize the ICD and DSM.74 Our results 
may also be used to inform future evaluations and revi-
sions of the new ICD-11 or DSM-5 diagnostic criteria. 
For example, given existing concerns that schizoaffective 
disorder may be a heterogeneous pathology in terms of 
the longitudinal course,75 we confirmed a good diagnos-
tic stability (0.72). We also found that about 0.16 initial 
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cases of ICD-10/DSM-IV schizoaffective disorder would 
shift towards schizophrenia. This value can be used as 
reference, to test if  the new DSM-5 diagnostic criteria for 
schizoaffective disorder76 have actually been successful at 
improving diagnostic reliability by shifting the concept 
from episode to life course of the disorder.
We also showed that first episode psychosis diagnoses 
other than schizophrenia or affective spectrum psychoses 
had a low diagnostic stability. Diagnostic changes were 
frequently to schizophrenia: 0.31 of initial psychosis not 
otherwise specified, 0.29 of initial delusional disorders, 
0.21 of initial acute and transient psychotic disorder/brief  
psychotic disorder, and 0.17 of initial substance-induced 
psychotic disorder. Because of these changes to schizo-
phrenia, the retrospective diagnostic stability of schizo-
phrenia spectrum disorders was low, suggesting that a 
significant number of the patients may be misdiagnosed at 
baseline. Careful monitoring and reassessment of patients 
presenting with unstable and remitting first episode diag-
noses, such as acute and transient psychotic disorder/brief  
psychotic disorder,77 seems especially important.
Specific predictors of diagnostic instability need to 
be determined in order to identify patients who may be 
misdiagnosed at baseline. We could not identify signifi-
cant meta-analytical variance in terms of age, gender, 
ICD-10 vs DSM-IV criteria, baseline GAF levels, dura-
tion of follow-up and comorbid substance abuse. We did 
not restrict first episode samples to a specific age range 
(eg, 16–35) to follow the new international guidelines 
that have eliminated young age as eligibility criterion to 
access early intervention services.78 The NICE CG 1.3.1.1 
recommends that “early intervention services should be 
accessible to all people with a first episode or first pre-
sentation of psychosis, irrespective of the person’s age 
or the duration of untreated psychosis”. Variability of 
age across the samples included in the current analysis 
allowed investigating its impact on meta-analytical out-
comes. For example, the median age of our sample was 
of 27 years, with a few outliers in the lower58 and upper 
range.57 However, the outliers had no impact on the meta-
analytical estimates, as shown by the sensitivity analyses 
(supplementary figure 2a and supplementary figure 2b). 
Furthermore, no significant change in diagnostic stabil-
ity was observed when the meta-analysis was repeated in 
the subset of studies enrolling first episode patients aged 
16 (footnotes a and b to table 3). Overall, the median age 
of our sample is consistent with evidence indicating that 
prodromal phase typically starts at 21 years and that it 
may last a few years.79 Another significant limitation of 
the current analysis is that we could not assess the impact 
of duration of untreated psychosis. Therefore the delay 
from the onset of symptoms to the diagnostic assess-
ment is undetermined. Meta-analyses carry over limita-
tions in the original studies and there were not enough 
studies reporting on these moderators. Similarly we can-
not exclude that other confounders not assessed by our 
meta-regressions such as quality of the diagnostic assess-
ment may have a significant impact on the diagnostic sta-
bility. However, we did assess the overall methodological 
quality of the included studies with the NOS16 and we 
found no significant effects for most ICD/DSM diagno-
ses, with the exception of ATPD/BPD. The lack of any 
effect of comorbid substance use may be due to the fact 
that different substances may have opposite effects on 
diagnostic stability. There is evidence for cannabis, but 
not stimulants, being associated with diagnostic instabil-
ity.80 With respect to duration of follow-up, the median 
follow-up time of the included studies was 2 years, there-
fore it is probable that most diagnostic changes would 
have already occurred by this time. Diagnostic re-assess-
ment of first episode cases early in the course of illness 
seems indicated. The lack of impact of baseline func-
tional level on diagnostic stability supports the recent 
decision of the DSM-5 Task Force to eliminate the GAF, 
an inadequate instrument for assessment of psychiatric 
functional impairment.81 Conversely, we found greater 
diagnostic stability when the initial diagnosis was formu-
lated in an inpatient unit as compared to a mixed clini-
cal setting. Specifically, our meta-analysis suggests that 
diagnostic stability of schizophrenia, affective spectrum 
psychoses, delusional disorder and acute and transient 
psychotic disorder/brief  psychotic disorder could be sig-
nificantly improved when the initial diagnosis is made in 
an inpatient unit. This finding supports an earlier report1 
and suggests that more severe psychopathology and/or 
more continuous observation maximizes stability of ini-
tial diagnosis.
Conclusions
There is meta-analytical evidence for high prospective 
diagnostic stability in schizophrenia spectrum psycho-
ses followed by affective spectrum psychoses, with no 
significant ICD/DSM differences. Diagnostic stability 
across the other first episode psychotic diagnoses was low 
and most of diagnostic changes were to schizophrenia. 
Diagnostic stability is important to patients and caretak-
ers and provides general guidance for clinical decision 
making. Stability is important for regulatory purposes 
and development of treatment guidelines. Addressing 
instability of diagnosis is an important challenge for 
future diagnostic development of early psychosis.
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Funding
This study was supported in part by a 2014 NARSAD 
Young Investigator Award to P.F-P. D.S. was supported 
 by guest on M
ay 31, 2016
http://schizophreniabulletin.oxfordjournals.org/
D
ow
nloaded from
 
Page 10 of 12
P. Fusar-Poli et al
in part funded by the National Institute for Health 
Research (NIHR) Biomedical Research Centre at South 
London and Maudsley National Health System (NHS) 
Foundation Trust and King’s College London. The views 
expressed are those of the author(s) and not necessarily 
those of the NIHR. 
Acknowledgment
The authors have declared that there are no conflicts of 
interest in relation to the subject of this study. Open access 
for this article was funded by King’s College London.
References
 1. Baca-Garcia E, Perez-Rodriguez M, et al. Diagnostic stability 
of psychiatric diagnoses in clinical practice. Brit J Psychiatry. 
2007;190:210–216.
 2. Insel T. Transforming Diagnosis. NIMH [Web]; 2013. http://
www.nimh.nih.gov/about/director/2013/transforming-diag-
nosis.shtml. Accessed October 12, 2015.
 3. Kapur S, Phillips AG, Insel TR. Why has it taken so long for 
biological psychiatry to develop clinical tests and what to do 
about it? Mol Psychiatry. 2012;17:1174–1179.
 4. Parnas J. The RDoC program: psychiatry without psyche? 
World Psychiatry. 2014;13:46–47.
 5. Coryell W. Diagnostic instability: how much is too much? Am 
J Psychiatry. 2011;168:1136–1138.
 6. Kendell R, Jablensky A. Distinguishing between the valid-
ity and utility of psychiatric diagnoses. Am J Psychiatry. 
2003;160:4–12.
 7. McGorry PD. Early clinical phenotypes, clinical staging, and 
strategic biomarker research: building blocks for personal-
ized psychiatry. Biol Psychiatry. 2013;74:394–395.
 8. Insel TR. Rethinking schizophrenia. Nature. 
2010;468:187–193.
 9. Jaaskelainen E, Juola P, Hirvonen N, et  al. A systematic 
review and meta-analysis of recovery in schizophrenia. 
Schizophr Bull. 2013;39:1296–1306.
 10. National Institute of Health and Care Excellence (NICE). 
Psychosis and schizophrenia in adults: prevention and man-
agement. NICE guidelines [CG178]. 2014. https://www.nice.
org.uk/guidance/cg178. Accessed February 1, 2016.
 11. Salvatore P, Baldessarini RJ, Tohen M, et  al. McLean-
Harvard International First-Episode Project: two-year sta-
bility of ICD-10 diagnoses in 500 first-episode psychotic 
disorder patients. J Clin Psychiatry. 2011;72:183–193.
 12. Schwartz JE, Fennig S, Tanenberg-Karant M, et  al. 
Congruence of diagnoses 2 years after a first-admission diag-
nosis of psychosis. Arch Gen Psychiatry. 2000;57:593–600.
 13. Heslin M, Lomas B, Lappin JM, et  al. Diagnostic change 
10  years after a first episode of psychosis. Psychol Med. 
2015;45:2757–2769.
 14. Stroup DF, Berlin JA, Morton SC, et  al. Meta-analysis of 
observational studies in epidemiology: a proposal for report-
ing. Meta-analysis Of Observational Studies in Epidemiology 
(MOOSE) group. JAMA. 2000;283:2008–2012.
 15. Moher D, Liberati A, Tetzlaff  J, Altman DG, Group P. 
Preferred reporting items for systematic reviews and meta-
analyses: the PRISMA statement. BMJ. 2009;339:b2535.
 16. Mertz D, Kim TH, Johnstone J, et al. Populations at risk for 
severe or complicated influenza illness: systematic review and 
meta-analysis. BMJ. 2013;347:f5061.
 17. Nyaga VN, Arbyn M, Aerts M. Metaprop: a Stata command 
to perform meta-analysis of binomial data. Arch Public 
Health. 2014;72:39.
 18. Newcombe RG. Two-sided confidence intervals for the sin-
gle proportion: comparison of seven methods. Stat Med. 
1998;17:857–872.
 19. Freeman MF, Tukey JW. Transformations related to the angu-
lar and the square root. Ann Math Stat. 1950;21:607–611.
 20. DerSimonian R, Laird N. Meta-analysis in clinical trials. 
Control Clinical Trial. 1986;7:177–188.
 21. Harbord R, Higgins J. Metaregression in Stata. Stat J. 
2008;8:493–519.
 22. Borenstein M, Hedges L, Higgins J, Rothstein H. Introduction 
to Meta-analysis. Chichester, UK: John Wiley & Sons; 
2009:421.
 23. Lang TA, Secic M. How to Report Statistics in Medicine: 
Annotated Guidelines for Authors, Editors and Reviewers. 2nd 
ed. Philadelphia, PA: American College of Physicians; 2006.
 24. Lipsey M, Wilson D. Practical Meta-analysis. Thousand 
Oaks, CA: Sage Publications; 2000.
 25. Steichen T. Nonparametric “trim and fill” analysis of pub-
lication bias in meta-analysis. Stata Technical Bulletin. 
2000;61:8–14.
 26. Peters JL, Sutton AJ, Jones DR, Abrams KR, Rushton L. 
Contour-enhanced meta-analysis funnel plots help distin-
guish publication bias from other causes of asymmetry. J Clin 
Epidemiol. 2008;61:991–996.
 27. Sterne JA, Egger M, Smith GD. Systematic reviews in health 
care: Investigating and dealing with publication and other 
biases in meta-analysis. BMJ. 2001;323:101–105.
 28. Duval S, Tweedie R. A nonparametric “trim and fill” method 
of accounting for publication bias in meta-analysis. J Am 
Stat Assoc. 2000;95:89–98.
 29. Amini H, Alaghband-rad J, Omid A, et al. Diagnostic stability 
in patients with first-episode psychosis. Australas Psychiatry. 
2005;13:388–392.
 30. Moller HJ, Jager M, Riedel M, Obermeier M, Strauss 
A, Bottlender R. The Munich 15-year follow-up study 
(MUFUSSAD) on first-hospitalized patients with schizo-
phrenic or affective disorders: assessing courses, types and 
time stability of diagnostic classification. Eur Psychiatry. 
2011;26:231–243.
 31. Jager MDM, Hintermayr M, Bottlender R, Strauss A, Moller 
HJ. Course and outcome of first-admitted patients with 
acute and transient psychotic disorders (ICD-10:F23). Focus 
on relapses and social adjustment. Eur Arch Psychiat Clin 
Neurosci. 2003;253:209–215.
 32. Okasha A, el Dawla AS, Khalil AH, Saad A. Presentation of 
acute psychosis in an Egyptian sample: a transcultural com-
parison. Compr Psychiatry. 1993;34:4–9.
 33. Jorgensen P. Comparative outcome of first-admission 
patients with delusional beliefs. Eur Psychiatry. 1995;10: 
276–281.
 34. Jorgensen P, Bennedsen B, Christensen J, Hyllested A. Acute 
and transient psychotic disorder: a 1-year follow-up study. 
Acta Psychiatrica Scandinavica. 1997;96:150–154.
 35. Das SK, Malhotra S, Basu D. Family study of acute and 
transient psychotic disorders: comparison with schizo-
phrenia. Soc Psychiatry Psychiatr Epidemiol. 1999;34: 
328–332.
 by guest on M
ay 31, 2016
http://schizophreniabulletin.oxfordjournals.org/
D
ow
nloaded from
 
Page 11 of 12
Diagnostic Stability of first episode psychosis
 36. Sajith SG, Chandrasekaran R, Sadanandan Unni KE, 
Sahai A. Acute polymorphic psychotic disorder: diagnos-
tic stability over 3  years. Acta Psychiatrica Scandinavica. 
2002;105:104–109.
 37. Jarbin H, von Knorring AL. Diagnostic stability in adoles-
cent onset psychotic disorders. Eur Child Adolesc Psychiatry. 
2003;12:15–22.
 38. Correll CU, Lencz T, Smith CW, et  al. Prospective study 
of  adolescents with subsyndromal psychosis: character-
istics and outcome. J Child Adolesc Psychopharmacol. 
2005;15:418–433.
 39. Rufino AC, Uchida RR, Vilela JA, Marques JM, Zuardi AW, 
Del-Ben CM. Stability of the diagnosis of first-episode psy-
chosis made in an emergency setting. Gen Hosp Psychiatry. 
2005;27:189–193.
 40. Schimmelmann BG, Conus P, Edwards J, McGorry PD, 
Lambert M. Diagnostic stability 18  months after treat-
ment initiation for first-episode psychosis. J Clin Psychiatry. 
2005;66:1239–1246.
 41. Suda K, Hayashi N, Hiraga M. Predicting features of later 
development of schizophrenia among patients with acute 
and transient psychotic disorder. Psychiatry Clin Neurosci. 
2005;59:146–150.
 42. Whitty P, Clarke M, McTigue O, Browne S, Kamali M, Larkin 
C, O’Callaghan E. Diagnostic stability four years after a first 
episode of psychosis. Psychiatr Serv. 2005;56:1084–1088.
 43. Abe T, Otsuka K, Kato S. Long-term clinical course of 
patients with acute polymorphic psychotic disorder with-
out symptoms of schizophrenia. Psychiatry Clin Neurosci. 
2006;60:452–457.
 44. Addington J, Chaves A, Addington D. Diagnostic stabil-
ity over one year in first-episode psychosis. Schizophr Res. 
2006;86:71–75.
 45. Thangadurai P, Gopalakrishnan R, Kurian S, Jacob KS. 
Diagnostic stability and status of acute and transient psy-
chotic disorders. Brit J Psychiatry. 2006;188:293.
 46. Boks MP, Selten JP, Leask S, Van den Bosch RJ. The 2-year 
stability of neurological soft signs after a first episode of non-
affective psychosis. Eur Psychiatry. 2006;21:288–290.
 47. Rahm C, Cullberg J. Diagnostic stability over 3 years in a total 
group of first-episode psychosis patients. Nordic J Psychiatry. 
2007;61:189–193.
 48. Subramaniam M, Pek E, Verma S, Chan YH, Chong SA. 
Diagnostic stability 2 years after treatment initiation in the 
early psychosis intervention programme in Singapore. Aust 
NZ J Psychiatry. 2007;41:495–500.
 49. Fraguas D, de Castro MJ, Medina O, et al. Does diagnostic 
classification of early-onset psychosis change over follow-up? 
Child Psychiatry Hum Dev. 2008;39:137–145.
 50. Haahr U, Friis S, Larsen TK, et al. First-episode psychosis: 
diagnostic stability over one and two years. Psychopathology. 
2008;41:322–329.
 51. Chang WC, Pang SL, Chung DW, Chan SS. Five-year stabil-
ity of ICD-10 diagnoses among Chinese patients presented 
with first-episode psychosis in Hong Kong. Schizophr Res. 
2009;115:351–357.
 52. Crebbin K, Mitford E, Paxton R, Turkington D. First-
episode drug-induced psychosis: a medium term follow up 
study reveals a high-risk group. Soc Psychiatry Psychiatr 
Epidemiol. 2009;44:710–715.
 53. Pedros A, Marti J, Gutierrez G, Tenias JM, Ruescas S. [Two-
year diagnostic stability and prognosis in acute psychotic epi-
sodes]. Actas espanolas de psiquiatria. 2009;37:245–251.
 54. Salem MO, Moselhy HF, Attia H, Yousef S. Psychogenic 
psychosis revisited: a follow up study. Int J Health Sci. 
2009;3:45–49.
 55. Salvatore P, Baldessarini RJ, Tohen M, et  al. McLean-
Harvard International First-Episode Project: two-year sta-
bility of DSM-IV diagnoses in 500 first-episode psychotic 
disorder patients. J Clin Psychiatry. 2009;70:458–466.
 56. Aadamsoo K, Saluveer E, Kuunarpuu H, Vasar V, Maron 
E. Diagnostic stability over 2  years in patients with acute 
and transient psychotic disorders. Nordic J Psychiatry. 
2011;65:381–388.
 57. Barak Y, Levy D, Szor H, Aizenberg D. First-onset functional 
brief  psychoses in the elderly. Can Geriatr J. 2011;14:30–33.
 58. Castro-Fornieles J, Baeza I, de la Serna E, et  al. Two-year 
diagnostic stability in early-onset first-episode psychosis. J 
Child Psychol Psychiatry. 2011;52:1089–1098.
 59. Kim JS, Baek JH, Choi JS, Lee D, Kwon JS, Hong KS. 
Diagnostic stability of first-episode psychosis and predictors 
of diagnostic shift from non-affective psychosis to bipolar 
disorder: a retrospective evaluation after recurrence. Psychiat 
Res. 2011;188:29–33.
 60. Narayanaswamy JC, Shanmugam VH, Raveendranathan D, 
Viswanath B, Muralidharan K. Short-term diagnostic sta-
bility of acute psychosis: data from a tertiary care psychi-
atric center in South India. Indian J Psychol Med. 2012;34: 
176–178.
 61. Pillmann F, Wustmann T, Marneros A. Acute and transient 
psychotic disorders versus persistent delusional disorders: 
a comparative longitudinal study. Psychiatry Clin Neurosci. 
2012;66:44–52.
 62. Kingston T, Scully PJ, Browne DJ, et al. Diagnostic trajec-
tory, interplay and convergence/divergence across all 12 
DSM-IV psychotic diagnoses: 6-year follow-up of the Cavan-
Monaghan First Episode Psychosis Study (CAMFEPS). 
Psychol Med. 2013;43:2523–2533.
 63. Pope MA, Joober R, Malla AK. Diagnostic stability of 
first-episode psychotic disorders and persistence of comor-
bid psychiatric disorders over 1  year. Can J Psychiatry. 
2013;58:588–594.
 64. Castagnini A, Foldager L. Epidemiology, course and out-
come of acute polymorphic psychotic disorder: implications 
for ICD-11. Psychopathology. 2014;47:202–206.
 65. Kapfhammer HP, Reininghaus EZ, Fitz W, Lange P. 
Clinical course of illness in women with early onset puer-
peral psychosis: a 12-year follow-up study. J Clin Psychiatry. 
2014;75:1096–1104.
 66. Queirazza F, Semple DM, Lawrie SM. Transition to schizo-
phrenia in acute and transient psychotic disorders. Brit J 
Psychiatry. 2014;204:299–305.
 67. Ranjan S, Shakya R, Shyangwa PM. Diagnostic stability of 
acute and transient psychotic disorders in patients attending 
tertiary care hospital. J Univers Coll Med Sci. 2015;2:7–10.
 68. Spitzer RL, Endicott J, Robins E. Research diagnos-
tic criteria: rationale and reliability. Arch Gen Psychiatry. 
1978;35:773–782.
 69. Koepsell TD, Gill DP, Chen B. Stability of clinical etiologic 
diagnosis in dementia and mild cognitive impairment: results 
from a multicenter longitudinal database. Am J Alzheimers 
Dis Other Demen. 2013;28:750–758.
 70. Albers L, Straube A, Landgraf MN, Heinen F, von Kries 
R. High diagnostic stability of confirmed migraine and con-
firmed tension-type headache according to the ICHD-3 beta 
in adolescents. J Headache Pain. 2014;15:36.
 by guest on M
ay 31, 2016
http://schizophreniabulletin.oxfordjournals.org/
D
ow
nloaded from
 
Page 12 of 12
P. Fusar-Poli et al
 71. Christian R, Saavedra L, Gaynes B, et  al. Future Research 
Needs for First- and Second-Generation Antipsychotics for 
Children and Young Adults. Future Research Needs Papers, 
No. 13. Rockville, MD: Agency for Healthcare Research and 
Quality (US); 2012. Report No.: 12-EHC042-EF.
 72. Citrome L, Kalsekar I, Guo Z, Laubmeier K, Hebden T. 
Diagnoses associated with use of atypical antipsychotics in 
a commercial health plan: a claims database analysis. Clin 
Ther. 2013;35:1867–1875.
 73. Morgan C, Lappin J, Heslin M, et  al. Reappraising 
the long-term course and outcome of psychotic dis-
orders: the AESOP-10 study. Psychol Med. 2014;44: 
2713–2726.
 74. First MB. Harmonisation of ICD-11 and DSM-V: oppor-
tunities and challenges. Brit J Psychiatry. 2009;195: 
382–390.
 75. Durla A, Lenciu M, Bredicean C, Papava I, Cristanovici M. 
Stability and change in the clinical course of schizoaffective 
disorder. Revista medico-chirurgicala a Societatii de Medici si 
Naturalisti din Iasi. 2013;117:11–15.
 76. Malaspina D, Owen MJ, Heckers S, et  al. Schizoaffective 
Disorder in the DSM-5. Schizophr Res. 2013;150:21–25.
 77. Fusar-Poli P, Cappucciati M, Bonoldi I, et al. Prognosis of 
brief  psychotic episodes: a meta-analysis. JAMA Psychiatry. 
2016;73:211–220.
 78. National Health Service. Achieving Better Access to Mental 
Health Services by 2020. London, England: Department of 
Health; 2014. https://www.gov.uk/government/publications/
mental-health-services-achieving-better-access-by-2020. 
Accessed February 1, 2016.
 79. Fusar-Poli P, Cappucciati M, Borgwardt S, et  al. 
Heterogeneity of  risk for psychosis within subjects at clinical 
high risk: meta-analytical stratification JAMA Psychiatry. 
2016;73:113–120.
 80. Sara GE, Burgess PM, Malhi GS, Whiteford HA, Hall WC. 
The impact of cannabis and stimulant disorders on diagnos-
tic stability in psychosis. J Clin Psychiatry. 2014;75:349–356.
 81. Gold LH. DSM-5 and the assessment of functioning: the 
World Health Organization Disability Assessment Schedule 
2.0 (WHODAS 2.0). J Am Acad Psychiatry. 2014;42:173–181.
 by guest on M
ay 31, 2016
http://schizophreniabulletin.oxfordjournals.org/
D
ow
nloaded from
 
